Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effectiveness of Anger Management Treatment in Reducing Anger-Related Behaviors in Female Juvenile Offenders
This study is currently recruiting participants.
Verified by National Institute of Mental Health (NIMH), August 2008
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00720486
  Purpose

This study will evaluate the effectiveness of an anger management treatment program, Juvenile Justice Anger Management for Girls, in reducing anger-related behaviors displayed by girls in the juvenile justice system.


Condition Intervention
Anger
Behavioral: Juvenile Justice Anger Management (JJAM) for Girls
Behavioral: Treatment as usual

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Subject), Parallel Assignment
Official Title: Anger Management Treatment for Female Juvenile Offenders

Further study details as provided by National Institute of Mental Health (NIMH):

Primary Outcome Measures:
  • Reduction in anger [ Time Frame: Measured at pretreatment, post-treatment, and Month 6 follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 72
Study Start Date: June 2008
Estimated Study Completion Date: February 2011
Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Participants will receive Juvenile Justice Anger Management for Girls plus treatment as usual.
Behavioral: Juvenile Justice Anger Management (JJAM) for Girls
JJAM will include two 1.5-hour group treatment sessions per week for 8 weeks. JJAM sessions will be manual based and will be designed to help youth develop skills in the following areas: identifying different types of physical and relational aggression, recognizing early warning signs of anger, avoiding anger-provoking situations, managing anger to prevent aggression, solving problems, communicating about anger-related events, and repairing relationships damaged by anger-related behaviors.
Behavioral: Treatment as usual
Treatment as usual will include standard activities in the female juvenile justice program.
2: Active Comparator
Participants will receive treatment as usual.
Behavioral: Treatment as usual
Treatment as usual will include standard activities in the female juvenile justice program.

Detailed Description:

Girls represent a growing segment of the juvenile justice population in the United States, with a large number of them being victims of sexual, physical, and psychological abuse. These girls have special needs in terms of treatment and rehabilitation; however, little research exists on effective mental health treatments for female juvenile offenders in justice facilities. Despite the severity of anger-related behaviors displayed by girls in the juvenile justice system, no anger management treatments have been systematically developed to meet the unique treatment needs of delinquent girls. Treatment programs that provide gender-specific education, counseling, and emotional support are necessary for addressing the aggressive behaviors and psychological distress often displayed among this population. One such treatment program, the Juvenile Justice Anger Management (JJAM) for Girls, is an anger management program adapted from Lochman's Coping Power program, an empirically supported school-based anger management treatment for younger children. This study will evaluate the effectiveness of JJAM for Girls in reducing anger-related behaviors displayed by girls in the juvenile justice system.

Participation in this study will last about 8 months. All participants will first undergo initial assessments that will include a combination of structured interviews, self-report measures, rating scales, and reviews of program behavioral records and incident reports. Participants will then be assigned randomly to receive JJAM for Girls plus treatment as usual or treatment as usual alone. Participants receiving JJAM for Girls will attend two 1.5-hour sessions per week for 8 weeks. Sessions will aim to help youth develop skills in the following areas: identifying different types of physical and relational aggression, recognizing early warning signs of anger, avoiding anger-provoking situations, managing anger to prevent aggression, solving problems, communicating about anger-related events, and repairing relationships damaged by anger-related behaviors. Participants will also complete between-session practice activities that will include practicing skills involved in planning personal goals. Treatment as usual for all participants will include all standard activities in the female juvenile justice program. All participants will repeat the initial assessments at treatment completion and Month 6 of follow-up.

  Eligibility

Ages Eligible for Study:   12 Years to 19 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Assigned to one of the designated juvenile justice facilities
  • Has the ability to speak, read, and understand English sufficiently well to complete the procedures of the study
  • Disposition to the juvenile justice program must last the 8 weeks of scheduled treatment plus 1 week before and after treatment

Exclusion Criteria:

  • Fails to complete pretreatment assessments
  • Current psychotic symptoms, mental retardation, or severe developmental disabilities
  • Considered to be a ward of the state (defined as a youth without a parent, either biological or adoptive, as the legal custodian)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00720486

Contacts
Contact: Christy Lane lanechristy@gmail.com

Locations
United States, Pennsylvania
Drexel University Recruiting
Philadelphia, Pennsylvania, United States, 19102
Contact: Christy Lane         lanechristy@gmail.com    
Principal Investigator: Naomi Goldstein, PhD            
Sponsors and Collaborators
Investigators
Principal Investigator: Naomi Goldstein, PhD Drexel University
  More Information

Responsible Party: Drexel University ( Naomi Goldstein, PhD )
Study ID Numbers: K23 MH070400, DSIR 82-SEMS
Study First Received: July 18, 2008
Last Updated: August 8, 2008
ClinicalTrials.gov Identifier: NCT00720486  
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on January 16, 2009